RxDoctor Payments Data

Jennifer Young

Family · White Lake, MINPI 1437521556

Payments from drug & device makers

$1,810in general payments, 2019–2025

Across 98 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$441
  • AstraZeneca$394
  • Lilly USA, LLC$206
  • Vanda Pharmaceuticals Inc.$123
  • Pfizer$112
  • GSK$79
  • plus $455 from 16 others

What the payments were for

  • Food & beverage$1,810100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,810 in reported general payments places this provider in the 80th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$9,176
Medicare patients
63
Services billed
170

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin50$50,553
MounjaroTirzepatide27$45,934
OzempicSemaglutide35$45,230
EliquisApixaban23$26,581
TrulicityDulaglutide16$21,448
XareltoRivaroxaban18$10,785
LinzessLinaclotide15$9,989
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$3,005
Atorvastatin Calcium178$2,353
Gabapentin83$2,191
Losartan Potassium110$1,661
Omeprazole97$1,427
Albuterol Sulfate HfaAlbuterol Sulfate46$1,421
Metoprolol Succinate99$1,236
Rosuvastatin Calcium87$1,045

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$206$67,38243 claims
Boehringer IngelheimJardiance$52$50,55350 claims
Novo NordiskOzempic$441$45,23035 claims
PfizerEliquis$112$26,58123 claims
Johnson & JohnsonXarelto$25$10,78518 claims
AbbVieLinzess$57$9,98915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,657 family providers in Michigan.

Other family in White Lake

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →